We are live on
!
Find out more
VIA
Vident Investment Advisory Portfolio holdings
AUM
$2.9B
1-Year Est. Return
24.67%
This Fund
S&P 500
This Quarter
Est. Return
+8.58%
1 Year Est. Return
+24.67%
3 Year Est. Return
+82.63%
5 Year Est. Return
+113.33%
10 Year Est. Return
–
AUM
$3.29B
AUM Growth
+$322M
(+11%)
Cap. Flow
+$111M
Cap. Flow
% of AUM
3.39%
Top 10 Holdings %
Top 10 Hldgs %
10.67%
Holding
1,133
New
146
Increased
560
Reduced
374
Closed
47
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iRhythm Holdings
IRTC
|
+$18.1M |
| 2 |
Apple
AAPL
|
+$9.12M |
| 3 |
AbbVie
ABBV
|
+$8.74M |
| 4 |
Meta Platforms (Facebook)
META
|
+$7.28M |
| 5 |
Comcast
CMCSA
|
+$7.16M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NUAN
Nuance Communications, Inc.
NUAN
|
+$29.7M |
| 2 |
NVIDIA
NVDA
|
+$8.28M |
| 3 |
Azenta
AZTA
|
+$7.66M |
| 4 |
Rockwell Automation
ROK
|
+$5.84M |
| 5 |
Intuitive Surgical
ISRG
|
+$5.55M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.68% |
| 2 | Healthcare | 14.09% |
| 3 | Energy | 12.28% |
| 4 | Industrials | 10.52% |
| 5 | Consumer Discretionary | 7.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1026
Qiagen
QGEN
$8.72B
| $216K | 0.01% |
4,208
-29,431
| -87% | -$1.52M |
|
1027
Veracyte
VCYT
$3.8B
| $216K | 0.01% |
+5,400
| New | +$231K |
|
1028
Alkermes
ALKS
$8.25B
| $214K | 0.01% |
+8,737
| New | +$194K |
|
1029
CarMax
KMX
$8.26B
| $214K | 0.01% |
1,657
+22
| +1% | +$2.72K |
|
1030
Regenxbio
RGNX
$708M
| $213K | 0.01% |
+5,482
| New | +$196K |
|
|
SAGE
1031
DELISTED
Sage Therapeutics
SAGE
| $213K | 0.01% |
+3,745
| New | +$265K |
|
1032
EnerSys
ENS
$6.99B
| $212K | 0.01% |
+2,173
| New | +$203K |
|
1033
NeoGenomics
NEO
$2.13B
| $212K | 0.01% |
+4,704
| New | +$208K |
|
|
NXGN
1034
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $212K | 0.01% |
+12,786
| New | +$229K |
|
1035
Adaptive Biotechnologies
ADPT
$3.97B
| $211K | 0.01% |
+5,155
| New | +$200K |
|
1036
Alector
ALEC
$199M
| $211K | 0.01% |
+10,124
| New | +$191K |
|
1037
Fiverr
FVRR
$339M
| $211K | 0.01% |
+870
| New | +$180K |
|
|
NVTA
1038
DELISTED
Invitae Corporation
NVTA
| $211K | 0.01% |
+6,245
| New | +$203K |
|
1039
Acadia Pharmaceuticals
ACAD
$5.03B
| $210K | 0.01% |
+8,608
| New | +$194K |
|
1040
Arcturus Therapeutics
ARCT
$211M
| $210K | 0.01% |
+6,205
| New | +$210K |
|
1041
MeiraGTx Holdings
MGTX
$1.21B
| $210K | 0.01% |
+13,546
| New | +$194K |
|
1042
Sarepta Therapeutics
SRPT
$1.77B
| $209K | 0.01% |
2,694
-3,483
| -56% | -$264K |
|
|
SDC
1043
DELISTED
SmileDirectClub, Inc. Class A Common Stock
SDC
| $209K | 0.01% |
+24,037
| New | +$222K |
|
1044
Natera
NTRA
$46.4B
| $208K | 0.01% |
+1,836
| New | +$188K |
|
1045
Schrodinger
SDGR
$1.36B
| $208K | 0.01% |
+2,748
| New | +$199K |
|
1046
Veeco
VECO
$3.23B
| $207K | 0.01% |
8,628
-39,608
| -82% | -$907K |
|
1047
AC Immune
ACIU
$240M
| $206K | 0.01% |
+25,974
| New | +$180K |
|
1048
Health Catalyst
HCAT
$128M
| $206K | 0.01% |
+3,708
| New | +$198K |
|
1049
PTC Therapeutics
PTCT
$6.12B
| $206K | 0.01% |
+4,863
| New | +$208K |
|
1050
4D Molecular Therapeutics
FDMT
$562M
| $205K | 0.01% |
+8,521
| New | +$261K |
|
Similar funds
EST
TCM
AWS
WI
JP
VCM
FCB
FCFS
Vident Investment Advisory's Q2 2021 Portfolio in Review
As of Q2 2021, Vident Investment Advisory held 1,133 positions worth $3.29B, up 11% from $2.97B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Vident Investment Advisory deployed $111M of net new capital in Q2 2021, opening 146 new positions and adding to 560 existing holdings. Its largest new stake was XPO: 59,887 shares worth $2.9M.
By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 31% a quarter earlier, followed by Healthcare and Energy.
On the sell side, the largest reduction was Nuance Communications, Inc., an estimated $29.7M trimmed.
- Vident Investment Advisory's largest Q2 2021 buy was XPO: 59,887 shares worth $2.9M.
- Vident Investment Advisory added most to iRhythm Holdings in Q2 2021, an estimated $18.1M increase.
- Vident Investment Advisory's biggest Q2 2021 reduction was Nuance Communications, Inc., cutting an estimated $29.7M.
- Vident Investment Advisory fully exited Cooper Tire & Rubber Co. in Q2 2021, selling an estimated $2.79M.
- Vident Investment Advisory's ten largest holdings make up 11% of its $3.29B portfolio in Q2 2021.
- Vident Investment Advisory opened 146 new positions and closed 47 in Q2 2021.
- Vident Investment Advisory's portfolio value rose 11% quarter-over-quarter to $3.29B.
Based on Vident Investment Advisory's 13F filing for Q2 2021, filed 13 Aug 2021.